Department of Neurology, University Hospital Eppendorf, Hamburg, Germany.
Mov Disord. 2013 Sep 15;28(11):1609-15. doi: 10.1002/mds.25677.
In patients with Parkinson's disease, gait and balance difficulties have emerged as some of the main therapeutic concerns. During earlier stages of the disease, the dopamine-responsive aspects of gait disorder can be treated initially with dopaminergic drugs or deep brain stimulation. However, certain temporal aspects of parkinsonian gait disorder remain therapeutically resistant in both the short term and the long term. In this review, we summarize the effects of deep brain stimulation on gait and postural symptoms in the five currently available targets (subthalamic nucleus, globus pallidus, ventralis intermedius thalamic nucleus, pedunculopontine nucleus, and substantia nigra) and describe programming strategies for patients who are mainly disabled by gait problems.
在帕金森病患者中,步态和平衡困难已成为一些主要的治疗关注点。在疾病的早期阶段,可最初使用多巴胺能药物或深部脑刺激来治疗与多巴胺反应相关的步态障碍。然而,在短期和长期内,帕金森步态障碍的某些时间方面仍然对治疗有抵抗力。在这篇综述中,我们总结了深部脑刺激对目前五个可用靶点(丘脑底核、苍白球、腹侧中间丘脑核、脑桥被盖核和黑质)的步态和姿势症状的影响,并描述了主要因步态问题而致残的患者的编程策略。